{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:4997"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:4997","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Characterisation of oncogenic LMP1 and CD40 signals in primary germinal centre B cells and their relevance to the pathogenesis Of Hodgkin’s lymphoma","abstract":"Latent membrane protein 1 (LMP1) is an oncogene expressed in a subset of germinal centre (GC)-derived lymphomas including Hodgkin’s lymphoma (HL) and diffuse large B cell lymphoma (DLBCL). However, LMP1 shares functional homology with CD40, a receptor required for normal GC B cell development. Dissecting how LMP1 functions differently from CD40 in GC cells is central to a better understanding of lymphomagenesis and is the subject of this thesis. In Chapter 3, I show that GC B cells can be successfully isolated from normal human tonsils and that these cells retain a GC phenotype upon short-term culture. In Chapter 4 I explore how the transcriptional programmes of LMP1 and CD40 differ in GC B cells and identify a subgroup of genes regulated by LMP1 but not by CD40, which are also concordantly regulated in primary HL cells from which I focus on sphingosine-1-phosphate receptor 2 (S1PR2). I confirm that S1PR2 is an LMP1 target in GC B cells and show that it is not expressed in the tumour cells of the majority of cases of HL and DLBCL. In DLBCL, S1PR2 loss is associated with LMP1 expression. I also provide preliminary evidence that the over-expression of S1PR2 can inhibit the HL cell migration. In Chapter 5, I report my initial attempts to optimise a method for the measurement of the activity of transcription factors in GC B cells which can be used to delineate those pathways activated by LMP1, but not by CD40, in GC B cells.","abstract_html":"Latent membrane protein 1 (LMP1) is an oncogene expressed in a subset of germinal centre (GC)-derived lymphomas including Hodgkin’s lymphoma (HL) and diffuse large B cell lymphoma (DLBCL). However, LMP1 shares functional homology with CD40, a receptor required for normal GC B cell development. Dissecting how LMP1 functions differently from CD40 in GC cells is central to a better understanding of lymphomagenesis and is the subject of this thesis. In Chapter 3, I show that GC B cells can be successfully isolated from normal human tonsils and that these cells retain a GC phenotype upon short-term culture. In Chapter 4 I explore how the transcriptional programmes of LMP1 and CD40 differ in GC B cells and identify a subgroup of genes regulated by LMP1 but not by CD40, which are also concordantly regulated in primary HL cells from which I focus on sphingosine-1-phosphate receptor 2 (S1PR2). I confirm that S1PR2 is an LMP1 target in GC B cells and show that it is not expressed in the tumour cells of the majority of cases of HL and DLBCL. In DLBCL, S1PR2 loss is associated with LMP1 expression. I also provide preliminary evidence that the over-expression of S1PR2 can inhibit the HL cell migration. In Chapter 5, I report my initial attempts to optimise a method for the measurement of the activity of transcription factors in GC B cells which can be used to delineate those pathways activated by LMP1, but not by CD40, in GC B cells.","abstract_has_math":false,"creators":["Nagy, Eszter"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-07","date_published":"2014-07","updated_at":"2026-11-19T09:27:58Z","subjects":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/4997/1/Nagy14PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A4997","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["bloodwise"]},{"key":"dc:creator","label":"Author","values":["Nagy, Eszter"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014-07"]},{"key":"dc:date.issued","label":"Date","values":["2014-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Medical & Dental Sciences","Institute of Cancer Studies"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/4997/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/4997/1/Nagy14PhD.pdf","http://etheses.bham.ac.uk//id/eprint/4997/2/Decl_IS_Nagy14PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Latent membrane protein 1 (LMP1) is an oncogene expressed in a subset of germinal centre (GC)-derived lymphomas including Hodgkin’s lymphoma (HL) and diffuse large B cell lymphoma (DLBCL). However, LMP1 shares functional homology with CD40, a receptor required for normal GC B cell development. Dissecting how LMP1 functions differently from CD40 in GC cells is central to a better understanding of lymphomagenesis and is the subject of this thesis. In Chapter 3, I show that GC B cells can be successfully isolated from normal human tonsils and that these cells retain a GC phenotype upon short-term culture. In Chapter 4 I explore how the transcriptional programmes of LMP1 and CD40 differ in GC B cells and identify a subgroup of genes regulated by LMP1 but not by CD40, which are also concordantly regulated in primary HL cells from which I focus on sphingosine-1-phosphate receptor 2 (S1PR2). I confirm that S1PR2 is an LMP1 target in GC B cells and show that it is not expressed in the tumour cells of the majority of cases of HL and DLBCL. In DLBCL, S1PR2 loss is associated with LMP1 expression. I also provide preliminary evidence that the over-expression of S1PR2 can inhibit the HL cell migration. In Chapter 5, I report my initial attempts to optimise a method for the measurement of the activity of transcription factors in GC B cells which can be used to delineate those pathways activated by LMP1, but not by CD40, in GC B cells."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Characterisation of oncogenic LMP1 and CD40 signals in primary germinal centre B cells and their relevance to the pathogenesis Of Hodgkin’s lymphoma"]}]}],"canonical_facts":{"dc:contributor.sponsor":["bloodwise"],"dc:creator":["Nagy, Eszter"],"dc:date":["2014-07"],"dc:date.issued":["2014-07"],"dc:description.abstract":["Latent membrane protein 1 (LMP1) is an oncogene expressed in a subset of germinal centre (GC)-derived lymphomas including Hodgkin’s lymphoma (HL) and diffuse large B cell lymphoma (DLBCL). However, LMP1 shares functional homology with CD40, a receptor required for normal GC B cell development. Dissecting how LMP1 functions differently from CD40 in GC cells is central to a better understanding of lymphomagenesis and is the subject of this thesis. In Chapter 3, I show that GC B cells can be successfully isolated from normal human tonsils and that these cells retain a GC phenotype upon short-term culture. In Chapter 4 I explore how the transcriptional programmes of LMP1 and CD40 differ in GC B cells and identify a subgroup of genes regulated by LMP1 but not by CD40, which are also concordantly regulated in primary HL cells from which I focus on sphingosine-1-phosphate receptor 2 (S1PR2). I confirm that S1PR2 is an LMP1 target in GC B cells and show that it is not expressed in the tumour cells of the majority of cases of HL and DLBCL. In DLBCL, S1PR2 loss is associated with LMP1 expression. I also provide preliminary evidence that the over-expression of S1PR2 can inhibit the HL cell migration. In Chapter 5, I report my initial attempts to optimise a method for the measurement of the activity of transcription factors in GC B cells which can be used to delineate those pathways activated by LMP1, but not by CD40, in GC B cells."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/4997/1/Nagy14PhD.pdf","http://etheses.bham.ac.uk//id/eprint/4997/2/Decl_IS_Nagy14PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Medical & Dental Sciences","Institute of Cancer Studies"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/4997/"],"dc:subject":["RC0254 Neoplasms. Tumors. Oncology (including Cancer)"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Characterisation of oncogenic LMP1 and CD40 signals in primary germinal centre B cells and their relevance to the pathogenesis Of Hodgkin’s lymphoma"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:27:58Z"}